This trial is evaluating whether Natural Treatment will improve 2 primary outcomes and 2 secondary outcomes in patients with Dermatitis, Seborrheic. Measurement will happen over the course of 6 months.
This trial requires 60 total participants across 2 different treatment groups
This trial involves 2 different treatments. Natural Treatment is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are in Phase 1 & 2 and have already been tested with other people.
Participation is compensated
You will be compensated for participating in this trial.
common treatments for dermatitis, seborrheic: use of antipsychotics; tetracycline topical preparations; antifungal cream; salicylic acid; ketoconazol topical solutions; benzoyl peroxide ; sulfur-containing creams; oral corticosteroids.
A staggering 8.5 million US adults reported having at least one dermatitis symptom in the last month. 1.9 million US adults reported at least one seborrheic symptom annually, and 8.2 million report them both. These estimates, along with a previous study showing nearly 11 million self-reported psoriasis (a dermatitis that the literature suggests is linked to psoriasis, or psoriasis-like dermatological symptoms), show that dermatitis and seborrheic are common to a huge number of Americans.
There is no evidence that a course of topical antimicrobial agent or counseling has any effect on chronic or acute dermatitis. There remains no evidence to support the idea that the presence of dermatitis or seborrheic affects the ability to cure other conditions related to sebaceous glands.
The skin irritation is caused by bacterial action. The bacteria produce peptides called acylated amino acids. These act in a similar fashion to human sweat gland proteins, and may be a cause or a consequence of acne and related skin conditions.
Seborrheic dermatitis, although usually a benign condition, can sometimes lead to chronic irritation of the scalp. In some such cases, one may need to be referred to a specialist.
A dermatitis is defined as a skin rash or inflammation associated with impaired sweat gland function. It is usually an acute disorder and usually a primary complaint when seen by a physician.
Primary contact dermatitis is more common in women, probably secondary to estrogen exposure. The secondary type of dermatitis occurs more frequently with seborrhea. Contact dermatitis due to irritants is not uncommon, especially when scalp hair is present or scalp hair is not washed properly. The cause of the secondary type of dermatitis is not known with a high probability.
While recent findings have increased our understanding of eczematous and psoriatic disease, there has been little advancement in understanding of non-dermatoskeletal disease. Despite the prevalence of the condition, skin disease is still largely treated on a symptomatic basis. The majority of sufferers will respond to topical corticosteroid therapy. While this therapy has improved their condition, it does not guarantee long-term remission. More severe manifestations of disease (erythema nodosum, chronic eczematous diseases such as pemphigus, and cutaneous lymphomas) respond somewhat better to systemic therapy, such as cyclophosphamide.
Application of an adequate herbal and mineral oil blend in combination with a topical antiseptic is most successful in treating seborrheic dermatitis on long-term follow-up.
Balsam of Peru [pura-pura (a resin)] is a popular herbal remedy touted as reducing hair loss and wrinkles. There are reports of severe allergic contact dermatitis with other botanical uses. This allergy in some cases is severe and has been fatal. Severe systemic adverse reaction due to ingestion of other substances containing balsam is also a hazard. We have highlighted an important note of this article: 'Natural treatment should not replace conventional treatments but instead be used in addition to conventional treatments, to treat any type of hair and skin ailments.
Most dermatitis, seborrheic cases can be managed in a short period of time, but a small percentage will require more specialized care. As more knowledge and advancements with regard to dermatology happen throughout time, some cases might actually require surgical removal.
This analysis of clinical trials for dermatitis (both seborrheic and atopic eczema) demonstrates substantial evidence that multiple studies for atopic dermatitis as well as for more severe dermatitis has been published. In addition, there is increasing evidence that seborrheic and atopic dermatitis respond similarly to a number of treatment options, and that the presence or absence of atopic dermatitis does not significantly alter the efficacy or efficacy/efficacy ratio of a medication for seborrheic dermatitis.